Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.16 EUR | +0.64% | -2.18% | -10.37% |
Mar. 18 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
Mar. 18 | Fresenius Settles With Johnson & Johnson to Market Stelara Alternative | DJ |
Official Publications
- Stock
- Equities
- Stock Fresenius SE & Co. KGaA - Xetra
- News Fresenius SE & Co. KGaA
- Official Publications